Preveceutical Med Inc New
(PRVCF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -282 | -1,140 | -1,391 | -797 | -475 |
| Depreciation Amortization | 2 | 8 | 3 | 2 | 1 |
| Accounts receivable | 10 | -2 | -4 | -4 | 1 |
| Other Working Capital | 98 | 381 | 272 | 166 | 49 |
| Other Operating Activity | 102 | 582 | 775 | 317 | 233 |
| Operating Cash Flow | $-71 | $-171 | $-345 | $-317 | $-192 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | 1 | 1 | 1 |
| Purchase Sale Intangibles | -2 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -2 | 1 | 0 | 0 | 0 |
| Investing Cash Flow | $-2 | $1 | $1 | $1 | $1 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 74 | 168 | 41 | 40 | 30 |
| Debt Issued | N/A | N/A | 53 | 23 | N/A |
| Common Stock Issued | N/A | N/A | -5 | -5 | 28 |
| Other Financing Activity | 0 | -5 | 0 | 0 | 0 |
| Financing Cash Flow | $74 | $163 | $89 | $58 | $58 |
| Exchange Rate Effect | -1 | 0 | 246 | 248 | 123 |
| Beginning Cash Position | 4 | 12 | 12 | 13 | 13 |
| End Cash Position | 5 | 4 | 2 | 2 | 3 |
| Net Cash Flow | $0 | $-8 | $-10 | $-11 | $-10 |
| Free Cash Flow | |||||
| Operating Cash Flow | -71 | -171 | -345 | -317 | -192 |
| Capital Expenditure | N/A | N/A | N/A | N/A | 1 |
| Free Cash Flow | -71 | -171 | -345 | -317 | -191 |